Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 6.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 31.1K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (31.1K versus 6.3K). Which is the better fit depends on your goals.
| DGNS | OBAT | |
|---|---|---|
Market Cap | 319B | 164.65B |
Volume | 6.3K | 31.1K |
Lot | 63 | 311 |
Turnover | 1.44M | 7.51M |
Average Price | 228.76 | 241.62 |
Value | 1.44M | 7.51M |
Indicative Equilibrium Price | 232 | 238 |
Indicative Equilibrium Volume | 200 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
